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The goal of this work is to establish an intensified downstream scheme for stable, high-titer monoclonal antibody 
(mAb) processes to achieve increased manufacturing productivity with short cadence, reduced cost, and small 
facility footprint. Several continuous manufacturing technologies including multi-column chromatography for 
capture, automated low-pH viral inactivation (low-pH VI), and integrated pool-less polishing steps were 
evaluated following consistent development methodologies for several mAbs. This presentation aims to provide 
an overview of the approaches to developing and integrating these discrete technologies in one cohesive 
process flow that fits manufacturing requirements in a flexible manner. Development efforts are illustrated in 
three major areas. First, twin-column continuous capture chromatography (CaptureSMB) was evaluated 
systematically for equivalency assessment comparing to traditional batch operation for different molecules. 
Development data showed overall comparable chromatography performance, while certain trends were found to 
be molecule/process specific. For executing viral clearance studies, scalable models were developed using 
CaptureSMB and a surrogate system employing standard batch chromatography with flow path modifications to 
mimic the loading strategy of CaptureSMB. We also introduce a model-assisted process characterization 
approach toward validation of continuous twin-column capture chromatography owing to increased process 
understanding. Second, experimental studies and computational fluid dynamics (CFD) modeling were used to 
reduce the risk of product aggregation in low-pH VI manufacturing operation. For various mixing systems, 
localized low-pH zones were characterized quantitatively to avoid the undesirable conditions that could cause 
severe aggregate formation during acid adjustment. The modeling tool integrated with mAb aggregation 
measurements facilitates the optimization of operating parameters (e.g., titrant addition rate, impeller agitation) 
and automation strategy to ensure robust VI scale-up performance. Third, various scenarios of integrated pool-
less polishing steps operated in flowthrough-flowthrough (FT-FT) or flowthrough-bind/elute (FT-B/E) mode were 
evaluated with or without inline adjustment between the two steps. Performance and quality attributes are 
compared for integrated and decoupled polishing steps, with an example describing the development and 
optimization workflow for a specific mAb process. Finally, implication to process development timelines, scale-
up performance and practical challenges to process implementation in the new 2000-L manufacturing facility will 
be discussed.  
 
 
